|Bid||1,155.00 x 0|
|Ask||1,157.40 x 0|
|Day's range||1,138.65 - 1,161.80|
|52-week range||505.00 - 1,161.80|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||838.46|
New Delhi, Jun 14 (PTI) Drug firm Lupin on Monday said its UK subsidiary has received approval from the regulatory authority to market Luforbec pressurised metered dose inhaler used for regular treatment of asthma in the UK market.
New Delhi, Jun 13 (PTI) Drug firm Lupin on Sunday said it has received a warning letter from the US health regulator for its Somerset facility in the US.
New Delhi, Jun 11 (PTI) Drug firm Lupin on Friday said that the company through its CSR arm, Lupin Foundation, is donating five oxygen generation plants to assist Maharashtra, Madhya Pradesh and Gujarat in their fight against the COVID-19 pandemic.